Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Scientific Corp (NYSE:BSX)

23.82
Delayed Data
As of Jan 13
 +0.30 / +1.28%
Today’s Change
15.67
Today|||52-Week Range
24.79
+10.12%
Year-to-Date
Boston Scientific's Upgrade May Lead to Breakout
Jan 13 / TheStreet.com - Paid Partner Content
Boston Scientific Charts Appear Boston Strong
Jan 11 / TheStreet.com - Paid Partner Content
Stock Market News for January 11, 2017
Jan 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close23.52
Today’s open23.51
Day’s range23.45 - 23.91
Volume9,486,079
Average volume (3 months)8,713,713
Market cap$32.4B
Dividend yield--
Data as of 4:01pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-100.00%
Earnings growth (this year)+18.55%
Earnings growth (next 5 years)+10.33%
Revenue growth (last year)+1.25%
P/E ratio476.4
Price/Sales3.34
Price/Book5.08

Competitors

 Today’s
change
Today’s
% change
BDXBecton Dickinson and...-0.14-0.08%
ZBHZimmer Biomet Holdin...+0.77+0.67%
BCRC R Bard Inc-1.10-0.47%
TFXTeleflex Inc+1.69+1.01%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$7.4B
Annual profit (last year)-$239.0M
Net profit margin-3.23%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael F. Mahoney
Executive Vice President-
Operations
Edward Mackey
Corporate headquarters
Marlborough, Massachusetts

Forecasts


Search for Jobs